Literature DB >> 19861499

Cayman ataxia protein caytaxin is transported by kinesin along neurites through binding to kinesin light chains.

Takane Aoyama1, Suguru Hata, Takeshi Nakao, Yuka Tanigawa, Chio Oka, Masashi Kawaichi.   

Abstract

Deficiency of caytaxin results in hereditary ataxia or dystonia in humans, mice and rats. Our yeast two-hybrid screen identified kinesin light chains (KLCs) as caytaxin-binding proteins. The tetratricopeptide-repeat region of KLC1 recognizes the ELEWED sequence (amino acids 115-120) of caytaxin. This motif is conserved among BNIP-2 family members and other KLC-interacting kinesin cargo proteins such as calsyntenins. Caytaxin associates with kinesin heavy chains (KHCs) indirectly by binding to KLCs, suggesting that caytaxin binds to the tetrameric kinesin molecule. In cultured hippocampal neurons, we found that caytaxin is distributed in both axons and dendrites in punctate patterns, and it colocalizes with microtubules and KHC. GFP-caytaxin expressed in hippocampal neurons is transported at a speed ( approximately 1 mum/second) compatible with kinesin movement. Inhibition of kinesin-1 by dominant-negative KHC decreases the accumulation of caytaxin in the growth cone. Caytaxin puncta do not coincide with vesicles containing known kinesin cargos such as APP or JIP-1. A part of caytaxin, however, colocalizes with mitochondria and suppression of caytaxin expression by RNAi redistributes mitochondria away from the distal ends of neurites. These data indicate that caytaxin binds to kinesin-1 and functions as an adaptor that mediates intracellular transport of specific cargos, one of which is the mitochondrion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861499     DOI: 10.1242/jcs.048579

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  22 in total

1.  The light chains of kinesin-1 are autoinhibited.

Authors:  Yan Y Yip; Stefano Pernigo; Anneri Sanger; Mengjia Xu; Maddy Parsons; Roberto A Steiner; Mark P Dodding
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

2.  Sunday Driver/JIP3 binds kinesin heavy chain directly and enhances its motility.

Authors:  Faneng Sun; Chuanmei Zhu; Ram Dixit; Valeria Cavalli
Journal:  EMBO J       Date:  2011-07-12       Impact factor: 11.598

Review 3.  The axonal transport of mitochondria.

Authors:  William M Saxton; Peter J Hollenbeck
Journal:  J Cell Sci       Date:  2012-05-22       Impact factor: 5.285

4.  Cayman ataxia-related protein is a presynapse-specific caspase-3 substrate.

Authors:  Masanori Itoh; Shimo Li; Kazunori Ohta; Aiko Yamada; Yoshika Hayakawa-Yano; Masashi Ueda; Yoko Hida; Yoshihiro Suzuki; Eri Ohta; Akihito Mizuno; Yoshiko Banno; Toshiyuki Nakagawa
Journal:  Neurochem Res       Date:  2011-03-03       Impact factor: 3.996

5.  Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells.

Authors:  Meredith H Wilson; Erika L F Holzbaur
Journal:  Development       Date:  2015-01-01       Impact factor: 6.868

6.  JIP3 Activates Kinesin-1 Motility to Promote Axon Elongation.

Authors:  Dana Watt; Ram Dixit; Valeria Cavalli
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

Review 7.  Coupling viruses to dynein and kinesin-1.

Authors:  Mark P Dodding; Michael Way
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

8.  A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome.

Authors:  Mark P Dodding; Richard Mitter; Ashley C Humphries; Michael Way
Journal:  EMBO J       Date:  2011-11-16       Impact factor: 11.598

9.  Mammalian diseases of phosphatidylinositol transfer proteins and their homologs.

Authors:  Aaron H Nile; Vytas A Bankaitis; Aby Grabon
Journal:  Clin Lipidol       Date:  2010-12-01

10.  Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export.

Authors:  Gareth W Morgan; Michael Hollinshead; Brian J Ferguson; Brendan J Murphy; David C J Carpentier; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.